Vanishing White Matter Disease With Periodic (Paroxysmal) Hemiparesis

van der Knaap, 1997, A new leukoencephalopathy with vanishing white matter, Neurology, 48, 845, 10.1212/WNL.48.4.845 Schiffmann, 1994, Childhood ataxia with diffuse central nervous system hypomyelination, Ann Neurol, 35, 331, 10.1002/ana.410350314 Leegwater, 2001, Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter, Nat Genet, 29, 383, 10.1038/ng764 Rodriquez, 1999, Phenotypic variation in leukoencephalopathy with vanishing white matter, Neurology, 53, 1373, 10.1212/WNL.53.6.1373 Fogli, 2004, The effect of genotype on the natural history of eIF2B-related leukodystrophies, Neurology, 62, 1509, 10.1212/01.WNL.0000123259.67815.DB van der Knaap, 1998, Phenotypic variation in leukoencephalopathy with vanishing white matter, Neurology, 51, 540, 10.1212/WNL.51.2.540 Espay, 2002, Episodic coma in a new leukodystrophy, Pediatr Neurol, 26, 139, 10.1016/S0887-8994(01)00356-3 Dietrich, 2005, EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy, Nat Med, 11, 277, 10.1038/nm1195 Montagna, 2004, The physiopathology of migraine, Neurol Sci, 25, S93, 10.1007/s10072-004-0261-0 Vahedi, 2000, CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy, Neurology, 55, 1040, 10.1212/WNL.55.7.1040 Thomsen, 2004, Sporadic hemiplegic migraine, Cephalalgia, 24, 1016, 10.1111/j.1468-2982.2004.00788.x Li, 2004, Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways, Mol Cell Biol, 24, 3295, 10.1128/MCB.24.8.3295-3306.2004 Fogli, 2004, Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients, Eur J Hum Genet, 12, 561, 10.1038/sj.ejhg.5201189 Dever, 2002, Gene-specific regulation by general translation factors, Cell, 108, 545, 10.1016/S0092-8674(02)00642-6